First breast cancer mammography screening program in Mexico: Initial results 2005-2006

Breast Journal

Volumn 15, Issue 6, 2009, Pages 623-631

  Rodríguez Cuevas, Sergio ^a   Guisa Hohenstein, Fernando ^b   Labastida Almendaro, Sonia ^c  

^a FUCAM   (Mexico)

^b FUCAM   (Mexico)

^c HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Breast cancer; Mammography; Screening

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; BREAST FEEDING; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CLINICAL EVALUATION; FAMILY HISTORY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEXICO; NULLIPARA; PARITY; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MEXICO; MIDDLE AGED; NEOPLASM STAGING; TIME FACTORS;

EID: 70349951079     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00811.x     Document Type: Article

References (55)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence. International Agency for Research on Cancer. World Health Organization. Lyon: IARC Press, 2002.
2. 2. Mettlin C. Global breast cancer mortality statistics. CA Cancer J Clin 1999;49:138-144 (Pubitemid 29353927)
3. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M. Cancer statistics 2006. JNCCN 2006;4:480-508.
4. Wilkinson JD, Wohler-Torres B, Trapido E, et al. Cancer trends among Hispanic men in South Florida 1981-1998. Cancer 2002;94:1183-1190
5. 5. Lara M, Gamboa C, Kahramaniau IM, Morales LS, Bautista DE. Acculturation and Latino Health in the United Status: a review of the literature and its sociopolitical context. Ann Rev Public Health 2005;26:367-397 (Pubitemid 40547389)
6. Compendio del Registro Histopatológico de Neoplasias en México. Morbilidad y Mortalidad 2001. Secretaria de Salud.
7. Rodríguez-Cuevas SA, Labastida AS, Tapia R, Kuri P, Macías C. Registro histopatológico de Neoplasias en México. Población derechohabiente del IMSS 1991-1996. Ciencia y Cultura Latinoamericana, México D.F 1999;56-60.
8. 8. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993;85:1819-1827 (Pubitemid 23333614)
9. Aceves EA. Boletín trimestral del Johnson Sc Johnson Medical Mexico. Johnson & Johnson Medical Bulletin 2003;3:7.
10. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
11. Ries LAG, Kosary CL, Hankey BF, Miller BA, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1995. Bethesda, MD: National Cancer Institute, 1998.
12. 12. Sondik EJ. Breast cancer trends: incidence, mortality and survival. Cancer 1994;74:995-999 (Pubitemid 24231993)
13. 13. Garfinkel L, Boring CC, Heath CW. Changing trends: an overview of breast cancer incidence and mortality. Cancer 1994; 74:222-227 (Pubitemid 24187634)
14. Gandey A, Berry D, Radvin P. Sharp decline in breast cancer linked to HRT. N Eng J Med 2007;36:1670-1674
15. 15. White E, Lee CY, Kristal AR. Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst 1990;82:1546-1552 (Pubitemid 20296504)
16. Miller BA, Feuer EJ, Hankey BF. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 1993;43:27-41.
17. Ryerson AB, Miller J, Eheman CR, White MC. Use of mammograms among women aged > 40 years, United States 2000-2005. Centers for Disease Control and Prevention. MMWR 2007;56:49-51.
18. World Health Organization Databank, http://www.who.org.
19. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents, Vol.VII. Lyon, France: IARC publication No. 143, 1997.
20. La Vecchia C, Negri E, Levi F, Decarli A. Age, cohort of birth, and period of death trends in breast cancer mortality in Europe. J Natl Cancer Inst 1997;89:732-734
21. 21. Nagata C, Kawakami N, Shimizu H. Trends in the incidence rate and risk factors for breast cancer in Japan. Breast Cancer Res Treat 1997;44:75-82. (Pubitemid 27179771)
22. 22. Rodríguez-Cuevas S, Macías CG, Franceschi D, Labastida S. Breast carcinoma presents a decade earlier in Mexican women than in women in the United Status or European countries. Cancer 2001;91:863-868 (Pubitemid 32173313)
23. Rodríguez-Cuevas S, Huerta BJ, Labastida AS. Tratamiento de las etapas III del cáncer de mama. Cir Gral 1997;19:211-215
24. 24. Calderon-Garcidueñas AL, Paras-Barrientos FU, CardenasIbarra L, et al. Risk factors of breast cancer in Mexican women. Salud Publica Mex 2000;42:26-33. (Pubitemid 30173470)
25. Peña-Gómez RM. Edad de la menarquia en tres grupos de niñas mexicanas. Departamento de Investigaciones antropológicas. INAH. Publicación 24. Secretaría de Educación Pública, México D.F. 1970
26. Tovar-Guzman V, Hernandez-Giron C, Lazcano-Ponce E, et al. Breast cancer in Mexican women: an epidemiological study with cervical cancer control. Rev Salud Publica 2000;34:113-119
27. La Salud en las Américas. Reporte de la Organización Panamericana de Salud. WHO.
28. 28. Tabar L, Chen HH, Duffy S, et al. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast cancer mortality. Cancer 2001;91:1724-1731 (Pubitemid 32377958)
29. Tabar L, Yen MF, Bitak B, et al. Mammographic service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003;361:140510.
30. Gotzsche PC, Olsen O. Screening mammography re-evaluated. Lancet 2000;355:752.
31. 31. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-1342 (Pubitemid 33016501)
32. 32. Michaelson JS, Kopans DB, Cady B. The breast carcinoma screening interval is important. Cancer 2000;88:1282-1284 (Pubitemid 30155162)
33. 33. Byers T, Mouehawar J, Marks J, et al. The American Cancer Society challenge goals: how far can cancer rates decline in the US by the year 2015? Cancer 1999;86:715-727 (Pubitemid 29379419)
34. Humprey LL, Helfand M, Chan BKS. Breast cancer screening with mammography. Summary of the Evidence for the U.S. Preventive Services Task Force, http://www.guideline.gov, 2002.
35. Norma Oficial Mexicana NOM-041-SSA2-2002, Para la prevención, diagnóstico, tratamiento, control y vigilancia epidemiológica del cáncer de mama. Diario Oficial Miércoles 17 de Septiembre de 2003.
36. Mexican Society of Oncology. Primera Revisión del Consenso Nacional sobre Tratamiento del Cáncer Mamario. Gineco y Obstet Mex 2002;70:349-360
37. 37. Cady B, Stone MD, Schuler JG, et al. The new era in breast cancer: invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996;131: 301-308 (Pubitemid 26078817)
38. Barth RJ. Breast cancers detected by mammography require less toxic therapy. Am J Roentgenol 2005;184:324-329
39. 39. Cady B. How to prevent invasive breast cancer. Detect and excise duct carcinoma in situ. J Surg Oncol 1998;69:60-62 (Pubitemid 28515960)
40. Bland KI, Menck HR, Scott-Conner CE, et al. The National Cancer Database. 10 year survey of breast cancer treatment at hospitals in the United States. Cancer 1998;83:1262-1273
41. SEER. Cancer Statistics Review 1975-2003. Bethesda MD: National Cancer Institute, 2006.
42. The American College of Radiology Breast Imaging Reporting Data System (BI-RADS). http://www.acr.org.
43. 43. Jimenez-Lee R, Oslak SG, Hedberg K, Vetto JT. Surgical outcomes of a breast cancer-screening program for low-income women. Arch Surg 2003;138:884-890 (Pubitemid 36960951)
44. Cortesi L, Chiuri VE, Ruscelli S, et al. Prognosis of screendetected breast cancers: results of a population based study. BMC Cancer 2006;6:17.
45. Wilson R, Duffy S, Andersson I, et al. European group for breast cancer screening. Program. Abstracts of the 3rd European Breast Cancer Conference, March 19-23, 2002, Barcelona Spain.
46. Junkermann H, Becker N, Peitgen HO. Concept and implementation of model projects for mammography screening in Germany. Radiologie 2001;41:328. 36
47. 47. Smith-Bindman R, Chu PW, Miglioretti DL, et al. Comparison of screening mammography in the United States and the United Kingdom. JAMA 2003;290:2129-2137 (Pubitemid 37432973)
48. 48. Skaane P, Skjennald A. Screen-film mammography versus full-field digital mammography with soft-copy reading. Randomized trial in a population-based screening program. Radiology 2004;232: 197-204. (Pubitemid 38787838)
49. 49. Destounis SV, DiNitto P, Logan-Young W, et al. Can computer-aided detection (CAD) with double reading of screening mammograms help decrease the false negative rate? Radiology 2004;232: 578-584 (Pubitemid 38971302)
50. 50. Birdwell RL, Bandodkar P. Computer-aided detection with screening mammography in a University Hospital setting. Radiology 2005;236:451-457 (Pubitemid 41023425)
51. La forza della prevenzione. Quello che le donne devano sapere. Azienda Sanitaria Locale, Brescia, Italy. ASL Informa Die 2004;12-15
52. Weaver DL, Rosenberg RD, Barlow WE, et al. Pathologic findings from the breast cancer sureveillance consortium.: population-based outcomes in women undergoing biopsy after screening mammography. Cancer 2006;106:732-742
53. Otten JDS, Karssemeiejer N, Hendriks JH, et al. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst 2005;97:748-754
54. Ohnuki K. Mammographic screening for non-palpable breast cancer in Japan. Breast Cancer 2005;12:258-266
55. Ries L, Eisner MP, Kosary C, et al. SEER Cancer Statistics Review 1975-2000. Bethesda, MD: National Cancer Institute, 2003.